Fig. 3From: Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO studyReceiver operator curves (ROC) displaying the sensitivity and specificity of (a) the breast cancer spheroid, (b) a multifactor model with baseline predictive factors (ER, PR, HER2, and age) impacting pCR, (c) model combining the breast cancer spheroid model, HER2-Status and type of therapy, and (d) breast cancer spheroid model combined with the factor of treatment adherence defined as treatment discontinuation, dose-reduction or change of treatment. The resulting area under the curve (AUC) is displayed at the top of each curveBack to article page